Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: A pilot study

Gastrointestinal Endoscopy

Volumn 55, Issue 3, 2002, Pages 335-341

  Deviére, Jacques ^a,b,c,d,e   Pastorelli, Alfredo ^a,b,c,d,e   Louis, Hubert ^a,b,c,d,e   De Maertelaer, Viviane ^b,c,d,e   Lehman, Glen ^a,b,c,d,e   Cicala, Michele ^a,b,c,d,e   Le Moine, Olivier ^a,b,c,d,e   Silverman, David ^a,b,c,d,e   Costamagna, Guido ^a,b,c,d,e  

^a ERASME HOSPITAL   (Belgium)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^e Enteric Medical Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE VINYL ALCOHOL COPOLYMER; ETHYLENE-VINYL ALCOHOL COPOLYMER; POLYVINYL DERIVATIVE; BIOPOLYMER; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BIODEGRADABLE IMPLANT; DIGESTIVE TRACT ENDOSCOPY; EVALUATION; GASTROESOPHAGEAL REFLUX; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LOWER ESOPHAGUS SPHINCTER; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPY; HEARTBURN; IMPLANTATION; LOWER ESOPHAGUS SPHINCTER PRESSURE; MANOMETRY; PRIORITY JOURNAL; RADIOGRAPHY; SCORING SYSTEM; STATISTICAL ANALYSIS; TECHNIQUE;

ABSORBABLE IMPLANTS; ADULT; AGED; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL REFLUX; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; PILOT PROJECTS; POLYVINYLS; TREATMENT OUTCOME;

EID: 0036511624     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.121596     Document Type: Article

References (10)

1. Locke GR 3rd, Talley NJ, Fell SL, Zinsmeister AR and Meltan LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
2. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21:953-6.
3. DeMeester TR. Definition, detection and pathophysiology of gastroesophageal reflux disease. In: DeMeester TR, Matthew H, editors. International trends in general thoracic surgery. Vol III. Benign esophageal disease. St Louis: Mosby; 1997. p. 99-127.
4. Liebermann DA. Medical therapy for chronic reflux esophagitis. A long-term follow up. Arch Int Med 1987;147:1717-20.
5. Patrick Waring J. Postfundoplication complications. Gastroenterol Clin North Am 1999;28:1007-19.
6. O'Connor MD, Lehman GA. Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux a pilot study of 10 medically intractable patients. Gastrointest Endosc 1988;34:106-12.
7. Shafik A. Intraesophageal Polytef injection for the treatment of reflux esophagitis. Surg Endosc 1996;10:329-31.
8. Schneider AJL. Assessment of risk factors and surgical outcome. Surg Clin North Am 1983;63:1113-26.
9. Terada T, Nakamura Y, Nakai K, Tsuura M, Nishiguchi T, Hayashi S, et al. Embolization of arteriovenous malformations with peripheral aneurysms using ethylene vinyl alcohol copolymer. Report of three cases. J Neurosurg 1991;75:655-60.
10. Mason RJ, Hughes M, Lehman GA, Chiao G, Deviére J, Silverman DE, et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer in a porcine model [abstract]. Surg Endosc 2000;14:8166-230.